From: Covered metallic stent for the treatment of malignant esophageal fistula combined with stricture
Total | group A | group B | P | |
---|---|---|---|---|
n | 37 | 26 | 11 | |
Gender, Male | 31 (83.8%) | 21 (80.8%) | 10 (90.9%) | 0.646 |
Median age (years) | 62.0 (54.5, 66) | 63.0 (54.8, 65.3) | 59.0 (53, 69) | 0.702 |
Esophageal mediastinal fistula | 23 (62.2%) | 14 (53.8%) | 9 (81.8%) | 0.150 |
Esophagopleural fistula | 14 (37.8%) | 12 (46.2%) | 2 (18.2%) | 0.150 |
Disease course before referral to hospital | 6.0 (3.0, 17.5) | 6.0 (3.0, 16.0) | 9.0 (3.8, 63.5) | 0.221 |
Interval between symptom and diagnosis | 2.0 (1.0, 5.0) | 2.0 (0.5, 5.4) | 3.0 (1.0, 5.0) | 0.133 |
Interval between diagnosis and treatment | 0.5 (0.2, 3.0) | 0.5 (0.2, 3.0) | 0.7 (0.1, 1.8) | 0.329 |
Patients with normal temperature | 13 (35.1%) | 9 (34.6%) | 4 (36.4%) | 1.000 |
Highest temperature of fever patients | 38.6 (38.4, 39.0) | 38.6 (38.2, 39.0) | 38.7 (38.4, 39.0) | 0.981 |
Highest leukocytes count (×109/L) | 9.2 (6.6, 12.3) | 8.9 (5.8, 11.6) | 11.3 (7.7, 18.0) | 0.831 |
Highest neutrophil (%) | 82.4 (75.1, 89.0) | 81.5 (68.2, 88.4) | 83.1 (79.3, 92.0) | 0.103 |